|
First Author (reference) |
Year | Type of health condition | Sample size (nondiabetic/diabetic) | Proportion of men, % (nondiabetic/diabetic) | Mean age, years (nondiabetic/diabetic) | Mean BMI, kg/m2 (nondiabetic/diabetic) | Adiposity assessment (method) |
Characteristics of participants | Effect size (95% confidence interval) |
Diabetic/prediabetic | Nondiabetic |
|
Gaborit [33] | 2012 | Type 2 diabetes mellitus | Nondiabetes | 17/13 | —a | 37/48 | 41.9/41.9 | MRIb | Obese | 4.72 (3.33, 6.12) |
|
Baum [34] | 2012 | Type 2 diabetes mellitus | Nondiabetes | 13/13 | 0/0 | 57/59 | 27.4/26.8 | CTc | Postmenopausal women | 0.44 (−0.34, 1.22) |
|
Hoyer [35] | 2011 | Type 2 diabetes mellitus | Nondiabetes | 386/103 | 51/54 | 51.2/57.9 | 23.8/25.3 | CT | Japanese-American (Japanese ancestry) | 0.73 (0.50, 0.95) |
|
Hanley [36] | 2011 | Type 2 diabetes mellitus | Nondiabetes | 1014/82 | 39/39 | 40.6/51.1 | 28.4/33.3 | CT | Hispanic and African American | 1.12 (0.89, 1.35) |
|
Bozzetto [37] | 2011 | Type 2 diabetes mellitus | Nondiabetes | 10/13 | 100/100 | 47/53 | 34.2/33.2 | MRI | Obese men | 0.30 (−0.53, 1.13) |
|
Kim [38] | 2010 | Type 2 diabetes mellitus | Nondiabetes | 21/38 | 100/100 | 28.6/29.2 | 24.8/26.8 | CT | Young men | 1.44 (−0.85, 2.03) |
|
Goel [39] | 2010 | Nondiabetes with metabolic syndrome (impaired fasting glucose) | Nondiabetes without metabolic syndrome | 65/35 | 60/37 | 29.1/36.1 | 21.5/27.5 | MRI | Asian Indians | 0.94 (0.51, 1.37) |
|
Ye [40] | 2009 | Type 2 diabetes mellitus | Nondiabetes | 86/28 | 100/100 | 53.6/57.6 | 24.2/26.9 | MRI | Chinese men | 0.57 (0.13, 1.00) |
|
Ye [40] | 2009 | Type 2 diabetes mellitus | Nondiabetes | 141/35 | 0/0 | 52.2/56.3 | 24.2/27.9 | MRI | Chinese women | 0.95 (0.56, 1.33) |
|
Shin [41] | 2009 | Insulin resistance (impaired fasting glucose) | Noninsulin resistant | 49/45 | 35/62 | 46/48.7 | 23.1/25.1 | CT | Koreans | 0.92 (0.50, 1.35) |
|
Rijzewijk [42] |
2008 | Type 2 diabetes mellitus | Nondiabetes | 28/38 | 100/100 | 54/57 | 26.9/28.1 | MRI | Elderly | 0.80 (0.30, 1.31) |
|
Kanda [43] | 2007 | Type 2 diabetes mellitus | Without metabolic syndrome | 147/111 | 100/100 | 63.6/58.1 | 21.3/27.3 | CT | Japanese men | 1.88 (1.59, 2.18) |
|
Kanda [43] | 2007 | Type 2 diabetes mellitus | Without metabolic syndrome | 94/67 | 0/0 | 61.2/60.4 | 22.6/27.2 | CT | Japanese women | 2.00 (1.62, 2.38) |
|
Dekker [44] | 2007 | Type 2 diabetes mellitus | Nondiabetes | 8/8 | 100/100 | 47.5/51 | 24.5/29.9 | MRI | Middle-aged men | 1.89 (0.71, 3.07) |
|
Azuma [45] | 2007 | Type 2 diabetes mellitus | Nondiabetes | 35/67 | 43/42 | 55/60 | 32.9/34.0 | CT | Elderly | 0.18 (−0.23, 0.59) |
|
Suwa [46] | 2006 | Type 2 diabetes mellitus | Nondiabetes | 7/24 | 0/0 | 47.6/51 | 24.1/26.1 | CT | Japanese women | 1.30 (0.39, 2.20) |
|
Kuk [47] | 2006 | Metabolic syndrome (impaired fasting glucose) | Nonmetabolic syndrome | 71/14 | 100/100 | 50.3/54.4 | 26.3/30.7 | CT | Caucasian men | 1.36 (0.75, 1.97) |
|
Kanaya [48] | 2006 | Type 2 diabetes mellitus | Nondiabetes | 2213/143 | 47/48 | 74/73 | 26.7/29.8 | CT | Elderly Caucasian and African American | 0.56 (0.39, 0.73) |
|
Iwasaki [49] | 2006 | Type 2 diabetes mellitus | Nondiabetes | 108/140 | 48/46 | 54.1/61.1 | 26.1/25.1 | CT | Japanese | 0.10 (−0.15, 0.35) |
|
Virtanen [50] | 2005 | Type 2 diabetes mellitus | Nondiabetes | 10/19 | 100/100 | 37/58 | 30.9/29.5 | MRI | Obese men | −0.12 (−0.89, 0.64) |
|
Virtanen [50] | 2005 | Type 2 diabetes mellitus | Nondiabetes | 20/12 | 100/100 | 37/58 | 24.5/25.5 | MRI | Nonobese men | 0.53 (−0.20, 1.26) |
|
Lee [51] | 2005 | Type 2 diabetes mellitus | Nondiabetes | 10/9 | 100/100 | 47.5/51 | 24.5/29.9 | CT | Middle-aged men | 2.39 (1.21, 3.57) |
|
Diamant [52] | 2005 | Type 2 diabetes mellitus | Nondiabetes | 16/16 | 75/75 | 54/54 | 24.4/25.9 | MRI | Men and postmenopausal women | 1.04 (0.30, 1.78) |
|
Kanaya [53] | 2004 | Type 2 diabetes mellitus with fasting plasma glucose ≥126 mg/dL | Nondiabetes (normal glucose tolerance) | 298/298 | 100/100 | 73.5/73.7d | 26.7/28.5 | CT | Elderly Caucasian and African American men | 0.48 (0.32, 0.64) |
|
Kanaya [53] | 2004 | Type 2 diabetes mellitus with fasting plasma glucose ≥126 mg/dL | Nondiabetes (normal glucose tolerance) | 221/221 | 0/0 | 73.5/73.7d | 27.5/30.8 | CT | Elderly Caucasian and African American women | 0.97 (0.77, 1.16) |
|
Gastaldelli [54] | 2004 | Type 2 diabetes mellitus with fasting plasma glucose <9 mM | Nondiabetes | 8/7 | — | 49/53 | 31.6/34.3 | MRI | Obese Caucasians and Mexican-American | 0.72 (−0.33, 1.77) |
|
Gastaldelli [54] | 2004 | Type 2 diabetes mellitus with fasting plasma glucose <9 mM | Nondiabetes | 8/9 | — | 41/56 | 24.4/26.8 | MRI | Nonobese Caucasians and Mexican-American | 0.60 (−0.38, 1.57) |
|
Gastaldelli [54] | 2004 | Type 2 diabetes mellitus with fasting plasma glucose >9 mM | Nondiabetes | 21/14 | — | 49/54 | 31.6/33.9 | MRI | Obese Caucasians and Mexican-American | 2.15 (1.31, 2.99) |
|
Gastaldelli [54] | 2004 | Type 2 diabetes mellitus with fasting plasma glucose >9 mM | Nondiabetes | 21/14 | — | 41/52 | 24.4/26.5 | MRI | Nonobese Caucasians and Mexican-American | 1.99 (1.17, 2.81) |
|
Anjana [55] | 2004 | Type 2 diabetes mellitus | Nondiabetes | 82/82 | 46/46 | 45/45 | 24.0/26.1 | CT | Asian Indians | 0.43 (0.12, 0.74) |
|
Ryan [56] | 2003 | Prediabetes (impaired glucose tolerance) | Nondiabetes | 100/17 | 0/0 | 46.5/56.1 | 26.5/34.0 | CT | Caucasian and African American women | 1.25 (0.71, 1.79) |
|
Kelley [57] | 2003 | Type 2 diabetes mellitus | Nondiabetes | 15/83 | — | 45.7/51.5 | 33.7/34.0 | CT | Obese | 1.18 (0.61, 1.76) |
|
Katsuki [58] | 2003 | Metabolically obese, normal weight individuals with normal glucose tolerance | Nondiabetes | 20/20 | 95/95 | 33.1/34.3 | 21.0/23.5 | CT | Japanese | 3.18 (2.25, 4.11) |
|
Hayashi [59] | 2003 | Impaired glucose tolerance | Normal glucose tolerance | 71/57 | 52/54 | 39.9/39.1 | 23.2/23.7 | CT | Japanese-American (3rd generation) | 0.41 (0.06, 0.77) |
|
Goodpaster [60] | 2003 | Type 2 diabetes mellitus | Normal glucose tolerance | 815/397 | 100/100 | 73.7/73.9 | 26.5/28.1 | CT | Elderly men | 0.39 (0.27, 0.51) |
|
Goodpaster [60] | 2003 | Type 2 diabetes mellitus | Normal glucose tolerance | 823/329 | 0/0 | 73.4/73.5 | 26.7/30.0 | CT | Elderly women | 0.80 (0.67, 0.93) |
|
Summers [61] | 2002 | Type 2 diabetes mellitus | Nondiabetes | 6/6 | 50/50 | 55/56 | 24/29 | MRT | Adults | 0.73 (−0.44, 1.90) |
|
Hernández-Ono [62] | 2002 | Type 2 diabetes mellitus | Nondiabetes | 39/9 | 0/0 | 55.7/56.2 | 27.6/27.5 | CT | Postmenopausal women | 0.02 (−0.70, 0.75) |
|
Liao [63] | 2001 | Impaired glucose tolerance | Normal glucose tolerance | 307/77 | 51/45 | 49.4/60.3 | 23.6/24.3 | CT | Japanese-American (Japanese ancestry, 2nd or 3rd generation) | 0.44 (0.19, 0.70) |
|
Liao [63] | 2001 | Type 2 diabetes mellitus | Normal glucose tolerance | 307/212 | 51/45 | 55.1/60.3 | 24.5/24.3 | CT | Japanese-American (Japanese ancestry, 2nd or 3rd generation) | 0.50 (0.33, 0.68) |
|
Boyko [64] | 2000 | Type 2 diabetes mellitus | Nondiabetes | 211/65 | 50/62 | 61.1/63.3 | 24.1/24.9 | CT | Japanese-American (2nd generation) | 0.40 (0.12, 0.68) |
|
Boyko [64] | 2000 | Type 2 diabetes mellitus | Nondiabetes | 192/13 | 51/77 | 40.0/43.1 | 23.7/27.7 | CT | Japanese-American (3rd generation) | 1.64 (1.06, 2.23) |
|
Nam [65] | 1999 | Type 2 diabetes mellitus | Nondiabetes | 12/12 | 100/100 | 41.6/45.0 | — | CT | Obese men | 0.07 (−0.73, 0.88) |
|
Mcneely [66] | 1999 | Type 2 diabetes mellitus | Nondiabetes | 212/23 | 100/100 | 51.3/55.9 | 25.1/26.8 | CT | Japanese-American men | 0.70 (0.27, 1.14) |
|
Mcneely [66] | 1999 | Type 2 diabetes mellitus | Nondiabetes | 158/17 | 0/0 | 51.0/60.3 | 22.6/23.5 | CT | Japanese-American women | 0.45 (−0.06, 0.95) |
|
Dvorak [67] | 1999 | Metabolically obese, normal weight | Nondiabetes | 58/13 | 0/0 | 28/29 | 21.5/22.5 | CT | Young normal weight women | 0.62 (0.01, 1.23) |
|
Vauhkonen [68] | 1998 | Type 2 diabetes mellitus with insulin sensitivity | Nondiabetes | 5/5 | 100/100 | 40.1/41.3d | 25.0/24.6d | CT | Men | 0.49 (−0.77, 1.75) |
|
Vauhkonen [68] | 1998 | Type 2 diabetes mellitus with insulin sensitivity | Nondiabetes | 9/15 | 0/0 | 40.1/41.3d | 25.0/24.6d | CT | Women | −0.36 (−1.19, 0.48) |
|
Vauhkonen [68] | 1998 | Type 2 diabetes mellitus with insulin resistance | Nondiabetes | 5/7 | 100/100 | 40.1/40.5d | 25.0/28.8d | CT | Men | 1.17 (−0.07, 2.40) |
|
Vauhkonen [68] | 1998 | Type 2 diabetes mellitus with insulin resistance | Nondiabetes | 9/11 | 0/0 | 40.1/40.5d | 25.0/28.8d | CT | Women | 0.09 (−0.80, 0.97) |
|
Fujimoto [69] | 1994 | Impaired glucose tolerance | Normal glucose tolerance | 93/22 | 100/100 | 39.6/40.2 | 24.5/26.8 | CT | Japanese-American men (3rd generation) | 0.85 (−0.37, 1.32) |
|
Fujimoto [69] | 1994 | Impaired glucose tolerance | Normal glucose tolerance | 79/36 | 0/0 | 40.8/39.8 | 22.5/23.3 | CT | Japanese-American women (3rd generation) | 0.65 (0.25, 1.05) |
|
Lemieux [70] | 1992 | Altered insulin-glucose homeostasis | Normal insulin-glucose homeostasis | 65/39 | 100/100 | 33.5/35.5 | 25.7/28.3 | CT | French ancestry men | 1.07 (0.65, 1.49) |
|
Gray [71] | 1991 | Type 2 diabetes mellitus | Nondiabetes | 12/24 | 0/0 | 37/57 | 35.4/38.6 | MRI | Obese women | 0.93 (0.21, 1.66) |
|